烟草而非大麻吸烟或联合用药与听力损失相关:2011至2012及2015至2016年美国国家健康与营养调查
该横断面人群研究纳入2705名参与者,分析烟草、大麻吸烟及联合用药与听力损失的关系。完全校正模型显示,烟草吸烟者高频听力损失风险增高(OR=1.64,95%CI 1.28-2.09),而大麻吸烟或联合用药与听力损失无统计学显著关联。
要点
- 烟草吸烟者高频听力损失风险较非吸烟者增高(OR=1.64,95%CI 1.28-2.09)。
- 大麻吸烟或联合用药与听力损失无统计学显著关联。
- 单纯使用大麻者较少且听力损失患病率低,限制结果外推。
核心结论
- 烟草吸烟可能是听力损失的危险因素,但不支持听力损失与大麻吸烟之间存在关联。
研究设计与样本
- 横断面人群研究,纳入2011至2012及2015至2016年美国国家健康与营养调查中2705名参与者,平均年龄39.41岁(SE:0.36)。
主要发现
- 年龄-性别校正模型中,烟草吸烟者较非吸烟者低频听力损失OR=1.58(95%CI 1.05-2.37),高频听力损失OR=1.97(95%CI 1.58-2.45)。
- 年龄-性别校正模型中,联合用药者较非吸烟者低频听力损失OR=2.07(95%CI 1.10-3.91),高频听力损失OR=2.24(95%CI 1.27-3.96)。
- 完全校正多变量模型中,烟草吸烟者较非吸烟者高频听力损失多变量校正OR=1.64(95%CI 1.28-2.09)。
- 完全校正模型中,听力损失(PTA 0.5,1,2或PTA 3,4,6,8)与大麻吸烟或联合用药之间无统计学显著关联。
局限性
- 单纯使用大麻相对少见,且该人群中听力损失患病率低,限制了结果的外推性。
- 作者提出需在吸烟者中采用听觉功能生理学测量及纵向研究以获得更确切证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A relationship between tobacco smoking and hearing loss has been reported; associations with cannabis smoking are unknown. In this cross-sectional population-based study, we examined relationships between hearing loss and smoking (tobacco, cannabis, or co-drug use). METHODS: We explored the relationship between hearing loss and smoking among 2705 participants [mean age = 39.41 (SE: 0.36) years] in the National Health and Nutrition Examination Survey (2011 to 12; 2015 to 16). Smoking status was obtained via questionnaire; four mutually exclusive groups were defined: nonsmokers, current regular cannabis smokers, current regular tobacco smokers, and co-drug users. Hearing sensitivity (0.5 to 8 kHz) was assessed, and two puretone averages (PTAs) computed: low- (PTA 0.5,1,2 ) and high-frequency (PTA 3,4,6,8 ). We defined hearing loss as threshold >15 dB HL. Multivariable logistic regression was used to examine sex-specific associations between smoking and hearing loss in the poorer ear (selected based on PTA 0.5,1,2 ) adjusting for age, sex, race/ethnicity, hypertension, diabetes, education, and noise exposure with sample weights applied. RESULTS: In the age-sex adjusted model, tobacco smokers had increased odds of low- and high-frequency hearing loss compared with non-smokers [odds ratio (OR) = 1.58, 95% confidence ratio (CI): 1.05 to 2.37 and OR = 1.97, 95% CI: 1.58 to 2.45, respectively]. Co-drug users also had greater odds of low- and high-frequency hearing loss [OR = 2.07, 95% CI: 1.10 to 3.91 and OR = 2.24, 95% CI: 1.27 to 3.96, respectively]. In the fully adjusted multivariable model, compared with non-smokers, tobacco smokers had greater odds of high-frequency hearing loss [multivariable adjusted odds ratio = 1.64, 95% CI: 1.28-2.09]. However, in the fully adjusted model, there were no statistically significant relationships between hearing loss (PTA 0.5,1,2 or PTA 3,4,6,8 ) and cannabis smoking or co-drug use. DISCUSSION: Cannabis smoking without concomitant tobacco consumption is not associated with hearing loss. However, sole use of cannabis was relatively rare and the prevalence of hearing loss in this population was low, limiting generalizability of the results. This study suggests that tobacco smoking may be a risk factor for hearing loss but does not support an association between hearing loss and cannabis smoking. More definitive evidence could be derived using physiological measures of auditory function in smokers and from longitudinal studies.
引用
- Baiduc RR, Sun JW, Spankovich C, et al. Tobacco, but Neither Cannabis Smoking Nor Co-Drug Use, Is Associated With Hearing Loss in the National Health and Nutrition Examination Survey, 2011 to 2012 and 2015 to 2016. Ear Hear. 2022. PMID: 35383601. doi:10.1097/AUD.0000000000001219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。